B BioNTech SE
| Market Cap | $22.92B |
| P/E Ratio | — |
| Forward P/E | -20.84 |
| Dividend Yield | — |
| Beta | 1.59 |
| 52W Range | $83.89 - $120.54 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Dodge & Cox Dodge & Cox | 0.19% | $344.10M | 3,614,491 | Reduce 0.89% |
Frequently Asked Questions
What is BNTX stock price today?
BioNTech SE (BNTX) is currently trading at $91.18. The stock has a 52-week range of $83.89 to $120.54 and a market capitalization of $22.92B.
Is BNTX a good stock to buy in 2026?
BioNTech SE has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of -0.9%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling BNTX stock?
There have been 0 insider transactions for BNTX in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has BNTX stock performed over the past year?
BioNTech SE (BNTX) has returned -0.9% over the past 12 months. The stock traded between $83.89 and $120.54 during this period, and is currently at $91.18.
Which hedge funds own BNTX (BioNTech SE)?
1 tracked hedge funds currently hold BNTX in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is BNTX's market cap and valuation?
BioNTech SE (BNTX) has a market capitalization of $22.92B. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is BNTX's revenue and profitability?
BioNTech SE reported revenue of $2.87B with net income of N/A and a profit margin of N/A. The stock has a beta of 1.59.
What sector is BNTX in and who are its biggest institutional holders?
BioNTech SE (BNTX) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.